BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6589023)

  • 1. Plasma alpha2-plasmin inhibitor levels in patients with leukemia.
    Kageyama T; Oyabu H; Dohi T; Matsumoto K; Tsumoto S
    Bull Osaka Med Sch; 1983 Jul; 29(1):36-42. PubMed ID: 6589023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
    Velasco F; Torres A; Andres P; Martinez F; Gomez P
    Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of alpha 2-plasmin inhibitor in patients with gastric cancer.
    Kageyama T; Oyabu H; Tsumoto S; Ohshiba S
    Bull Osaka Med Sch; 1984 Oct; 30(2):89-95. PubMed ID: 6571385
    [No Abstract]   [Full Text] [Related]  

  • 6. [Levels of antithrombin III and alpha 2-plasmin inhibitor in bone marrow aspirate].
    Tsurumi N; Hayashi H; Ishimaru F; Fujita T; Takai Y; Tsuda T; Kimura I
    Rinsho Ketsueki; 1988 Aug; 29(8):1207-13. PubMed ID: 3204671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intravascular coagulation syndrome in acute leukemia].
    Faĭnshteĭn FE; Lagutina NIa; Chizhova AI; Fedulova GA; Klimovich LG
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):10-3. PubMed ID: 6929065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis and pathologic physiology of disseminated intravascular coaguration (DIC) in patients with acute promyelocytic leukemia (author's transl)].
    Ando Y; Watanabe K
    Rinsho Ketsueki; 1976 Apr; 17(4):389-95. PubMed ID: 1066493
    [No Abstract]   [Full Text] [Related]  

  • 10. [In-vitro "thromboplastic" activity of leukocytes and intravascular blood coagulation in leukemias].
    Gouault-Heilmann M; Varet B; Romano C; Josso F
    Pathol Biol (Paris); 1972 Dec; ():Suppl:56-64. PubMed ID: 4574606
    [No Abstract]   [Full Text] [Related]  

  • 11. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ; García Avello A
    Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disseminated intravascular coagulation in blastic leukemia].
    Genova V; Georgiev Z
    Vutr Boles; 1974; 13(2):89-90. PubMed ID: 4529499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma fibronectin in acute myeloid leukemia].
    García Frade LJ; García Avello A; Obispo T; Alava I; Odriozola J; Cesar J; Pardo A; Navarro JL
    Sangre (Barc); 1984; 29(4-A):376-83. PubMed ID: 6594781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorrhage in the cases with leukemia].
    Sakuragawa N; Kondo S
    Rinsho Byori; 1984 Sep; 32(9):954-8. PubMed ID: 6084083
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
    Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
    Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulable state and hemorrhage in acute leukemias.
    He LZ; Lu LH
    Chin Med J (Engl); 1988 Jun; 101(6):448-53. PubMed ID: 3146479
    [No Abstract]   [Full Text] [Related]  

  • 18. [Care of patients with acute promyelocytec leukemia complicated by disseminated intravascular coagulation].
    Huizhen S
    Zhonghua Hu Li Za Zhi; 1982 Oct; (5):282-3. PubMed ID: 6961963
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha 2-plasmin inhibitor and its deficiency states.
    Saito H
    J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
    [No Abstract]   [Full Text] [Related]  

  • 20. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.